{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:25:07Z","timestamp":1791991507181,"version":"4.4.0"},"reference-count":133,"publisher":"Portland Press Ltd.","issue":"5","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,3,15]]},"abstract":"<jats:p>In chronic kidney disease (CKD), influx of urea and other retained toxins exerts a change in the gut microbiome. There is decreased number of beneficial bacteria that produce short-chain fatty acids, an essential nutrient for the colonic epithelium, concurrent with an increase in bacteria that produce uremic toxins such as indoxyl sulphate, p-cresyl sulphate, and trimethylamine-N-oxide (TMAO). Due to intestinal wall inflammation and degradation of intercellular tight junctions, gut-derived uremic toxins translocate into the bloodstream and exert systemic effects. In this review, we discuss the evidence supporting a role for gut-derived uremic toxins in promoting multiorgan dysfunction via inflammatory, oxidative stress, and apoptosis pathways. End-organ effects include vascular calcification, kidney fibrosis, anemia, impaired immune system, adipocyte dysfunction with insulin resistance, and low turnover bone disease. Higher blood levels of gut-derived uremic toxins are associated with increased cardiovascular events and mortality in the CKD population. Clinical trials that have examined interventions to trap toxic products or reverse gut microbial dysbiosis via oral activated charcoal AST-120, prebiotics and probiotics have not shown impact on cardiovascular or survival outcomes but were limited by sample size and short trials. In summary, the gut microbiome is a major contributor to adverse cardiovascular outcomes and progression of CKD.<\/jats:p>","DOI":"10.1042\/cs20171107","type":"journal-article","created":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T01:35:11Z","timestamp":1520645711000},"page":"509-522","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":226,"title":["Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins"],"prefix":"10.1042","volume":"132","author":[{"given":"Wei\u00a0Ling","family":"Lau","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, University of California, Irvine, Orange, CA, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Savoj","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Riverside Community Hospital, University of California, Riverside School of Medicine, Riverside, CA, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael\u00a0B.","family":"Nakata","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, University of California, Irvine, Orange, CA, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosratola\u00a0D.","family":"Vaziri","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, University of California, Irvine, Orange, CA, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"2021113011031884400_B1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev.mi.31.100177.000543","article-title":"Microbial ecology of the gastrointestinal tract","volume":"31","author":"Savage","year":"1977","journal-title":"Annu. Rev. Microbiol."},{"key":"2021113011031884400_B2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"2021113011031884400_B3","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int."},{"key":"2021113011031884400_B4","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1681\/ASN.2013080905","article-title":"The gut microbiome, kidney disease, and targeted interventions","volume":"25","author":"Ramezani","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B5","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions between the microbiota and the immune system","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"key":"2021113011031884400_B6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.smim.2011.01.011","article-title":"Commensal flora and the regulation of inflammatory and autoimmune responses","volume":"23","author":"Kranich","year":"2011","journal-title":"Semin. Immunol."},{"key":"2021113011031884400_B7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nri1373","article-title":"Interactions between commensal intestinal bacteria and the immune system","volume":"4","author":"Macpherson","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"2021113011031884400_B8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nature12506","article-title":"Richness of human gut microbiome correlates with metabolic markers","volume":"500","author":"Le Chatelier","year":"2013","journal-title":"Nature"},{"key":"2021113011031884400_B9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"2021113011031884400_B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.smim.2011.11.007","article-title":"The dialog between microbiota and the immune system: shaping the partners through development and evolution","volume":"24","author":"Cerf-Bensussan","year":"2012","journal-title":"Semin. Immunol."},{"key":"2021113011031884400_B11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev.nutr.22.011602.092259","article-title":"How host-microbial interactions shape the nutrient environment of the mammalian intestine","volume":"22","author":"Hooper","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"2021113011031884400_B12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1073\/pnas.28.7.285","article-title":"Synthesis of vitamins by intestinal bacteria","volume":"28","author":"Burkholder","year":"1942","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011031884400_B13","doi-asserted-by":"publisher","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011031884400_B14","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00125-006-0334-0","article-title":"Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?","volume":"49","author":"Brugman","year":"2006","journal-title":"Diabetologia"},{"key":"2021113011031884400_B15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1177\/153537020422900702","article-title":"Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models","volume":"229","author":"Huycke","year":"2004","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"2021113011031884400_B16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1073\/pnas.0605374104","article-title":"Mechanisms underlying the resistance to diet-induced obesity in germ-free mice","volume":"104","author":"B\u00e4ckhed","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011031884400_B17","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.2174\/138161208784480207","article-title":"Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease","volume":"14","author":"Isolauri","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"2021113011031884400_B18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/ndt\/gfu343","article-title":"The intestine-renal connection in IgA nephropathy","volume":"30","author":"Coppo","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113011031884400_B19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000181424","article-title":"Bacterial populations of the small intestine in uremia","volume":"22","author":"Simenhoff","year":"1978","journal-title":"Nephron"},{"key":"2021113011031884400_B20","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/S0140-6736(76)91207-1","article-title":"Amine metabolism and the small bowel in uraemia","volume":"2","author":"Simenhoff","year":"1976","journal-title":"Lancet"},{"key":"2021113011031884400_B21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000071292","article-title":"Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth","volume":"67","author":"Strid","year":"2003","journal-title":"Digestion"},{"key":"2021113011031884400_B22","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1016\/j.bbagen.2012.12.006","article-title":"Exhaled breath and fecal volatile organic biomarkers of chronic kidney disease","volume":"1830","author":"Meinardi","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113011031884400_B23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1053\/j.jrn.2011.07.003","article-title":"Effect of hemodialysis and diet on the exhaled breath methanol concentration in patients with ESRD","volume":"22","author":"Lee","year":"2012","journal-title":"J. Ren. Nutr."},{"key":"2021113011031884400_B24","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ki.2012.345","article-title":"Chronic kidney disease alters intestinal microbial flora","volume":"83","author":"Vaziri","year":"2013","journal-title":"Kidney Int."},{"key":"2021113011031884400_B25","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1159\/000360010","article-title":"Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD","volume":"39","author":"Wong","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"2021113011031884400_B26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1159\/000381990","article-title":"The gut as a source of inflammation in chronic kidney disease","volume":"130","author":"Lau","year":"2015","journal-title":"Nephron"},{"key":"2021113011031884400_B27","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1111\/hdi.12553","article-title":"Oral iron supplementation: Potential implications for the gut microbiome and metabolome in patients with CKD","volume":"21","author":"Kortman","year":"2017","journal-title":"Hemodial. Int."},{"key":"2021113011031884400_B28","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/gutjnl-2014-307720","article-title":"Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants","volume":"64","author":"Jaeggi","year":"2015","journal-title":"Gut"},{"key":"2021113011031884400_B29","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.trstmh.2005.10.016","article-title":"Iron supplementation increases small intestine permeability in primary schoolchildren in Lusaka, Zambia","volume":"100","author":"Nchito","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"2021113011031884400_B30","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B31","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1038\/ki.2009.402","article-title":"Uremic toxins originating from colonic microbial metabolism","author":"Evenepoel","year":"2009","journal-title":"Kidney Int. Suppl."},{"key":"2021113011031884400_B32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0925-4439(91)90046-C","article-title":"Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide","volume":"1096","author":"Bell","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113011031884400_B33","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1093\/ndt\/gfk056","article-title":"Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis","volume":"21","author":"Bain","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113011031884400_B34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/ndt\/gfv095","article-title":"Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment","volume":"31","author":"Vaziri","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113011031884400_B35","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1525-139X.2009.00576.x","article-title":"Protein-bound toxins\u2013update 2009","volume":"22","author":"Jourde-Chiche","year":"2009","journal-title":"Semin. Dial."},{"key":"2021113011031884400_B36","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/clinchem\/34.11.2264","article-title":"Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography","volume":"34","author":"Niwa","year":"1988","journal-title":"Clin. Chem."},{"key":"2021113011031884400_B37","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"2021113011031884400_B38","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1681\/ASN.2005030310","article-title":"Removal of P-cresol sulfate by hemodialysis","volume":"16","author":"Martinez","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5935\/0101-2800.20160024","article-title":"p-cresol but not p-cresyl sulfate stimulate MCP-1 production via NF-\u03baB p65 in human vascular smooth muscle cells","volume":"38","author":"Maciel","year":"2016","journal-title":"J. Bras. Nefrol."},{"key":"2021113011031884400_B40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000185973","article-title":"Phenylacetylglutamine and hippuric acid in uremic and healthy subjects","volume":"55","author":"Zimmerman","year":"1990","journal-title":"Nephron"},{"key":"2021113011031884400_B41","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1046\/j.1523-1755.2003.00906.x","article-title":"Uremic toxins of organic anions up-regulate PAI-1 expression by induction of NF-kappaB and free radical in proximal tubular cells","volume":"63","author":"Motojima","year":"2003","journal-title":"Kidney Int."},{"key":"2021113011031884400_B42","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/ndt\/gfl584","article-title":"P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production","volume":"22","author":"Schepers","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113011031884400_B43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.arcmed.2014.04.002","article-title":"Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease","volume":"45","author":"Rossi","year":"2014","journal-title":"Arch. Med. Res."},{"key":"2021113011031884400_B44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1159\/000351758","article-title":"Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease","volume":"38","author":"Moradi","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"2021113011031884400_B45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature10434","article-title":"Peripheral education of the immune system by colonic commensal microbiota","volume":"478","author":"Lathrop","year":"2011","journal-title":"Nature"},{"key":"2021113011031884400_B46","first-page":"608","article-title":"Pathology of gastrointestinal tract in chronic hemodialysis patients: an autopsy study of 78 cases","volume":"80","author":"Vaziri","year":"1985","journal-title":"Am. J. Gastroenterol."},{"key":"2021113011031884400_B47","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1159\/000186158","article-title":"Increased intestinal permeability to differently sized polyethylene glycols in uremic rats: effects of low- and high-protein diets","volume":"56","author":"Magnusson","year":"1990","journal-title":"Nephron"},{"key":"2021113011031884400_B48","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/gut.32.7.754","article-title":"Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure","volume":"32","author":"Magnusson","year":"1991","journal-title":"Gut"},{"key":"2021113011031884400_B49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/01.mog.0000203864.48255.4f","article-title":"Regulation of the intestinal epithelial barrier by the apical junctional complex","volume":"22","author":"Laukoetter","year":"2006","journal-title":"Curr. Opin. Gastroenterol."},{"key":"2021113011031884400_B50","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1093\/ndt\/gfr624","article-title":"Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation","volume":"27","author":"Vaziri","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113011031884400_B51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000353764","article-title":"Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction","volume":"38","author":"Vaziri","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"2021113011031884400_B52","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s10620-014-3428-4","article-title":"Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption","volume":"60","author":"Lau","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"2021113011031884400_B53","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1440-1797.2012.01647.x","article-title":"Gut bacterial translocation is associated with microinflammation in end-stage renal disease patients","volume":"17","author":"Wang","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"2021113011031884400_B54","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s10620-014-3202-7","article-title":"Gut bacterial translocation may aggravate microinflammation in hemodialysis patients","volume":"59","author":"Shi","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"2021113011031884400_B55","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1053\/j.jrn.2011.05.004","article-title":"Examining associations of circulating endotoxin with nutritional status, inflammation, and mortality in hemodialysis patients","volume":"22","author":"Feroze","year":"2012","journal-title":"J. Ren. Nutr."},{"key":"2021113011031884400_B56","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2215\/CJN.03600807","article-title":"Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients","volume":"3","author":"Szeto","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2215\/CJN.04610510","article-title":"Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease","volume":"6","author":"McIntyre","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B58","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1007\/s10620-012-2242-0","article-title":"Gut bacterial translocation contributes to microinflammation in experimental uremia","volume":"57","author":"Wang","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"2021113011031884400_B59","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1159\/000343886","article-title":"Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium","volume":"36","author":"Vaziri","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"2021113011031884400_B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000345969","article-title":"Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"2021113011031884400_B61","doi-asserted-by":"publisher","first-page":"G851","DOI":"10.1152\/ajpgi.2000.279.5.G851","article-title":"Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells","volume":"279","author":"Nusrat","year":"2000","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"2021113011031884400_B62","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.2741\/3413","article-title":"Mechanism of cytokine modulation of epithelial tight junction barrier","volume":"14","author":"Al-Sadi","year":"2009","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"2021113011031884400_B63","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1681\/ASN.2010121220","article-title":"Colonic contribution to uremic solutes","volume":"22","author":"Aronov","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B64","first-page":"S211","article-title":"Indoxyl sulfate stimulates renal synthesis of transforming growth factor-beta 1 and progression of renal failure","volume":"63","author":"Miyazaki","year":"1997","journal-title":"Kidney Int. Suppl."},{"key":"2021113011031884400_B65","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ. Res."},{"key":"2021113011031884400_B66","doi-asserted-by":"publisher","first-page":"e108448","DOI":"10.1371\/journal.pone.0108448","article-title":"Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand","volume":"9","author":"Ichii","year":"2014","journal-title":"PLoS ONE"},{"key":"2021113011031884400_B67","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"p-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int."},{"key":"2021113011031884400_B68","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/ki.2012.434","article-title":"Nox4 as a potential therapeutic target for treatment of uremic toxicity associated to chronic kidney disease","volume":"83","author":"Gorin","year":"2013","journal-title":"Kidney Int."},{"key":"2021113011031884400_B69","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"2021113011031884400_B70","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(08)60952-6","article-title":"All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan","volume":"371","author":"Wen","year":"2008","journal-title":"Lancet"},{"issue":"Supplement 3","key":"2021113011031884400_B71","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1053\/ajkd.2000.19928","article-title":"Cardiovascular disease in chronic renal insufficiency","volume":"36","author":"Levin","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"2021113011031884400_B72","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ajkd.2003.07.016","article-title":"Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences","volume":"42","author":"Kalantar-Zadeh","year":"2003","journal-title":"Am. J. Kidney Dis."},{"key":"2021113011031884400_B73","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/ncpneph0954","article-title":"Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease","volume":"4","author":"Kendrick","year":"2008","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"2021113011031884400_B74","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.semnephrol.2012.12.011","article-title":"Clinical detection, risk factors, and cardiovascular consequences of medial arterial calcification: a pattern of vascular injury associated with aberrant mineral metabolism","volume":"33","author":"Lau","year":"2013","journal-title":"Semin. Nephrol."},{"key":"2021113011031884400_B75","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.2215\/CJN.03980609","article-title":"Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients","volume":"4","author":"Barreto","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B76","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.arcmed.2012.08.002","article-title":"Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease","volume":"43","author":"Lin","year":"2012","journal-title":"Arch. Med. Res."},{"key":"2021113011031884400_B77","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2215\/CJN.04730514","article-title":"Association of indoxyl sulfate with heart failure among patients on hemodialysis","volume":"10","author":"Cao","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B78","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ki.2013.133","article-title":"Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway","volume":"84","author":"Gondouin","year":"2013","journal-title":"Kidney Int."},{"key":"2021113011031884400_B79","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.taap.2010.02.007","article-title":"2,3,7,8-tetrachlorodibenzo-p-dioxin increases reactive oxygen species production in human endothelial cells via induction of cytochrome P4501A1","volume":"245","author":"Kopf","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2021113011031884400_B80","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1681\/ASN.2013121283","article-title":"The cardiovascular effect of the uremic solute indole-3 acetic acid","volume":"26","author":"Dou","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B81","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/ndt\/gfp592","article-title":"Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease","volume":"25","author":"Liabeuf","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113011031884400_B82","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.2215\/CJN.07971109","article-title":"p-Cresol and cardiovascular risk in mild-to-moderate kidney disease","volume":"5","author":"Meijers","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B83","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1093\/ndt\/gfq251","article-title":"Serum protein-bound uraemic toxins and clinical outcomes in haemodialysis patients","volume":"25","author":"Lin","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113011031884400_B84","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-2369-15-87","article-title":"Cardiovascular disease relates to intestinal uptake of p-cresol in patients with chronic kidney disease","volume":"15","author":"Poesen","year":"2014","journal-title":"BMC Nephrol."},{"key":"2021113011031884400_B85","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"key":"2021113011031884400_B86","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1681\/ASN.2014111063","article-title":"Serum trimethylamine-N-oxide is elevated in CKD and correlates with coronary atherosclerosis burden","volume":"27","author":"Stubbs","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B87","first-page":"S234","article-title":"Serum levels of polyamines in patients with chronic renal failure","volume":"16","author":"Saito","year":"1983","journal-title":"Kidney Int. Suppl."},{"key":"2021113011031884400_B88","first-page":"451","article-title":"A uremic peptide containing polyamine: formation and possible role in uremic hypertriglyceridemia","volume":"12","author":"Lutz","year":"1980","journal-title":"Physiol. Chem. Phys."},{"key":"2021113011031884400_B89","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1681\/ASN.2015121302","article-title":"Microbiota-derived phenylacetylglutamine associates with overall mortality and cardiovascular disease in patients with CKD","volume":"27","author":"Poesen","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B90","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiota dysbiosis contributes to the development of hypertension","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome"},{"key":"2021113011031884400_B91","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/hep.27698","article-title":"Attenuated portal hypertension in germ-free mice: function of bacterial flora on the development of mesenteric lymphatic and blood vessels","volume":"61","author":"Moghadamrad","year":"2015","journal-title":"Hepatology"},{"key":"2021113011031884400_B92","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1002\/mnfr.201500290","article-title":"Antihypertensive effects of probiotics Lactobacillus strains in spontaneously hypertensive rats","volume":"59","author":"G\u00f3mez-Guzm\u00e1n","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"2021113011031884400_B93","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.114.03469","article-title":"Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials","volume":"64","author":"Khalesi","year":"2014","journal-title":"Hypertension"},{"key":"2021113011031884400_B94","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00467-008-0762-9","article-title":"What is new in uremic toxicity?","volume":"23","author":"Vanholder","year":"2008","journal-title":"Pediatr. Nephrol."},{"key":"2021113011031884400_B95","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1538-7836.2004.00837.x","article-title":"Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia","volume":"2","author":"Bonomini","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"2021113011031884400_B96","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1159\/000191468","article-title":"Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells","volume":"29","author":"Tumur","year":"2009","journal-title":"Am. J. Nephrol."},{"key":"2021113011031884400_B97","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1253\/circj.CJ-10-0117","article-title":"Indoxyl sulfate stimulates monocyte chemoattractant protein-1 expression in human umbilical vein endothelial cells by inducing oxidative stress through activation of the NADPH oxidase-nuclear factor-\u03baB pathway","volume":"74","author":"Masai","year":"2010","journal-title":"Circ. J."},{"key":"2021113011031884400_B98","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.bbrc.2011.05.084","article-title":"Nitric oxide counters the inhibitory effects of uremic toxin indoxyl sulfate on endothelial cells by governing ERK MAP kinase and myosin light chain activation","volume":"409","author":"Kharait","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113011031884400_B99","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1744-9987.2010.00884.x","article-title":"New insight into the redox properties of uremic solute indoxyl sulfate as a pro- and anti-oxidant","volume":"15","author":"Miyamoto","year":"2011","journal-title":"Ther. Apher. Dial."},{"key":"2021113011031884400_B100","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1053\/j.jrn.2011.10.027","article-title":"Indoxyl sulfate induces endothelial cell senescence by increasing reactive oxygen species production and p53 activity","volume":"22","author":"Adelibieke","year":"2012","journal-title":"J. Ren. Nutr."},{"key":"2021113011031884400_B101","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bbrc.2010.07.130","article-title":"Indoxyl sulfate, a uremic toxin, promotes cell senescence in aorta of hypertensive rats","volume":"399","author":"Adijiang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113011031884400_B102","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"2021113011031884400_B103","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1161\/01.RES.0000141775.67189.98","article-title":"Pathophysiology of vascular calcification in chronic kidney disease","volume":"95","author":"Moe","year":"2004","journal-title":"Circ. Res."},{"key":"2021113011031884400_B104","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/sj.ki.5000340","article-title":"Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells","volume":"69","author":"Yamamoto","year":"2006","journal-title":"Kidney Int."},{"key":"2021113011031884400_B105","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/ki.1995.64","article-title":"Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol","volume":"47","author":"Vanholder","year":"1995","journal-title":"Kidney Int."},{"key":"2021113011031884400_B106","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/labinvest.2011.114","article-title":"Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner","volume":"91","author":"Chiang","year":"2011","journal-title":"Lab. Invest."},{"key":"2021113011031884400_B107","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1053\/j.jrn.2014.10.011","article-title":"Role of uremic toxins in erythropoiesis-stimulating agent resistance in chronic kidney disease and dialysis patients","volume":"25","author":"Nangaku","year":"2015","journal-title":"J. Ren. Nutr."},{"key":"2021113011031884400_B108","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2369-14-244","article-title":"Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate","volume":"14","author":"Ahmed","year":"2013","journal-title":"BMC Nephrol."},{"key":"2021113011031884400_B109","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/ndt\/gfv367","article-title":"The role of adipose tissue asymmetric dimethylarginine\/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats","volume":"31","author":"Minakuchi","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113011031884400_B110","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/10715762.2015.1125996","article-title":"The uremic toxin indoxyl sulfate exacerbates reactive oxygen species production and inflammation in 3T3-L1 adipose cells","volume":"50","author":"Stockler-Pinto","year":"2016","journal-title":"Free Radic. Res."},{"key":"2021113011031884400_B111","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1681\/ASN.2012050503","article-title":"p-Cresyl sulfate promotes insulin resistance associated with CKD","volume":"24","author":"Koppe","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B112","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/sj.ki.5002097","article-title":"Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells","volume":"71","author":"Nii-Kono","year":"2007","journal-title":"Kidney Int."},{"key":"2021113011031884400_B113","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.bone.2015.06.010","article-title":"Indoxyl sulfate exacerbates low bone turnover induced by parathyroidectomy in young adult rats","volume":"79","author":"Hirata","year":"2015","journal-title":"Bone"},{"key":"2021113011031884400_B114","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/MAJ.0b013e3182989f26","article-title":"Association of indoxyl sulfate with fibroblast growth factor 23 in patients with advanced chronic kidney disease","volume":"347","author":"Lin","year":"2014","journal-title":"Am. J. Med. Sci."},{"key":"2021113011031884400_B115","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/sdi.12348","article-title":"Dietary restrictions in dialysis patients: is there anything left to eat?","volume":"28","author":"Kalantar-Zadeh","year":"2015","journal-title":"Semin. Dial."},{"key":"2021113011031884400_B116","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1189\/jlb.0112023","article-title":"Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease","volume":"93","author":"Ito","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"2021113011031884400_B117","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1159\/000351171","article-title":"Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"2021113011031884400_B118","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1053\/j.jrn.2011.10.015","article-title":"AST-120 ameliorates epithelial-to-mesenchymal transition and interstitial fibrosis in the kidneys of chronic kidney disease rats","volume":"22","author":"Bolati","year":"2012","journal-title":"J. Ren. Nutr."},{"key":"2021113011031884400_B119","first-page":"535","article-title":"Cardiorenal protective effect of the oral uremic toxin absorbent AST-120 in chronic heart disease patients with moderate CKD","volume":"23","author":"Shibahara","year":"2010","journal-title":"J. Nephrol."},{"key":"2021113011031884400_B120","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.metabol.2010.01.023","article-title":"Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generation","volume":"60","author":"Nakamura","year":"2011","journal-title":"Metabolism"},{"key":"2021113011031884400_B121","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1053\/j.ajkd.2009.05.011","article-title":"Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial","volume":"54","author":"Akizawa","year":"2009","journal-title":"Am. J. Kidney Dis."},{"key":"2021113011031884400_B122","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014010042","article-title":"Randomized placebo-controlled EPPIC trials of AST-120 in CKD","author":"Schulman","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B123","doi-asserted-by":"publisher","first-page":"e114881","DOI":"10.1371\/journal.pone.0114881","article-title":"High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease","volume":"9","author":"Vaziri","year":"2014","journal-title":"PLoS ONE"},{"key":"2021113011031884400_B124","doi-asserted-by":"publisher","first-page":"F857","DOI":"10.1152\/ajprenal.00513.2015","article-title":"Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats","volume":"310","author":"Kieffer","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113011031884400_B125","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1093\/ndt\/gfp414","article-title":"p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin","volume":"25","author":"Meijers","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"2021113011031884400_B126","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.2215\/CJN.00490114","article-title":"Effect of increasing dietary fiber on plasma levels of colon-derived solutes in hemodialysis patients","volume":"9","author":"Sirich","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B127","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/ejcn.2014.237","article-title":"Dietary fiber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials","volume":"69","author":"Chiavaroli","year":"2015","journal-title":"Eur. J. Clin. Nutr."},{"key":"2021113011031884400_B128","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.116.024545","article-title":"High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice","volume":"135","author":"Marques","year":"2017","journal-title":"Circulation"},{"key":"2021113011031884400_B129","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sj.ki.5001523","article-title":"Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study","volume":"70","author":"Evenepoel","year":"2006","journal-title":"Kidney Int."},{"key":"2021113011031884400_B130","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s12325-010-0059-9","article-title":"Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease","volume":"27","author":"Ranganathan","year":"2010","journal-title":"Adv. Ther."},{"key":"2021113011031884400_B131","doi-asserted-by":"publisher","first-page":"568571","DOI":"10.1155\/2014\/568571","article-title":"Randomized controlled trial of strain-specific probiotic formulation (Renadyl) in dialysis patients","volume":"2014","author":"Natarajan","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"2021113011031884400_B132","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2215\/CJN.05240515","article-title":"Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): a randomized trial","volume":"11","author":"Rossi","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021113011031884400_B133","doi-asserted-by":"publisher","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","article-title":"The Reactome Pathway Knowledgebase","volume":"46","author":"Fabregat","year":"2018","journal-title":"Nucleic Acids Res."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/132\/5\/509\/446594\/cs-2017-1107c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/132\/5\/509\/446594\/cs-2017-1107c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T11:57:49Z","timestamp":1638273469000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/132\/5\/509\/72110\/Altered-microbiome-in-chronic-kidney-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":133,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,3,15]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20171107","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]}}}